Cite
Abstract C128: Development of therapeutic anti-Jagged1 monoclonal antibodies
MLA
Ji-Liang Li, et al. “Abstract C128: Development of Therapeutic Anti-Jagged1 Monoclonal Antibodies.” Molecular Cancer Therapeutics, vol. 14, Dec. 2015, p. C128. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........aef8a2ec8c46bba5b9d1cccbb0f04bd2&authtype=sso&custid=ns315887.
APA
Ji-Liang Li, Demin Li, Stephen M. Stribbling, Penny A. Handford, Carol Bentley, Adrian L. Harris, Massimo Masiero, Sarah K. Watts, Susan M. Lea, Jenny Greig, Tasneem Hassanali, Pat Whiteman, Alison H. Banham, & Jenna Yates. (2015). Abstract C128: Development of therapeutic anti-Jagged1 monoclonal antibodies. Molecular Cancer Therapeutics, 14, C128.
Chicago
Ji-Liang Li, Demin Li, Stephen M. Stribbling, Penny A. Handford, Carol Bentley, Adrian L. Harris, Massimo Masiero, et al. 2015. “Abstract C128: Development of Therapeutic Anti-Jagged1 Monoclonal Antibodies.” Molecular Cancer Therapeutics 14 (December): C128. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........aef8a2ec8c46bba5b9d1cccbb0f04bd2&authtype=sso&custid=ns315887.